B9156

Butorphanol (+)-tartrate salt

≥99%

• 同義詞: L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan (+)-tartrate salt
• 經驗公式（希爾表示法）: C₂₁H₂₉NO₂ · C₄H₆O₆
• CAS號碼: 58786-99-5
• 分子量：: 477.55
• EC號碼: 261-443-5
• MDL號碼: MFCD00214257
• 分類程式碼代碼: 12352200
• PubChem物質ID: 24892126
• NACRES: NA.77

屬性

• 化驗: ≥99%
• 形狀: powder
• 藥物控制: USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada
• 起源: Bristol-Myers Squibb
• 儲存溫度: 2-8°C
• SMILES 字串: O[C@H]([C@@H](O)C(O)=O)C(O)=O.Oc1ccc2C[C@H]3N(CC[C@@]4(CCCC[C@@]34O)c2c1)CC5CCC5
• InChI: 1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;1-,2-/m11/s1
• InChI 密鑰: GMTYREVWZXJPLF-BTVKVFNOSA-N
• 基因資訊: human ... OPRK1(4986) , OPRM1(4988)

描述

生化／生理作用

κ/μ opioid receptor agonist.

特點和優勢

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全資訊

• 象形圖: GHS08,GHS07
• 訊號詞: Warning
• 危險聲明: H302,H361
• 防範說明: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• 危險分類: Acute Tox. 4 Oral - Repr. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges